What Biomedical Instruments does

Biomedical Instruments Co., Ltd. (BI) is a privately held Chinese medical device manufacturer founded in 1993 and headquartered in Shenzhen. The company designs and produces cardiocerebrovascular diagnostic and monitoring equipment, with a product portfolio centered on four lines: Holter ECG systems (including the BI9900/BI9100 recorders, Holter Patch BIP-03A, and dedicated analysis software), Ambulatory Blood Pressure Monitors (BP60B and TeleABP BI5000/BI5000B), PC-based ECG equipment, and a cloud-based Cardiology Information System (CIS) that integrates data from these devices and third-party instruments for centralized analysis, reporting, and telemedicine. Notable technical features include 99.8% QRS detection accuracy validated against AHA and MIT databases, up to 30-day Holter recording times, a 29g IP68 waterproof Bluetooth 5.0 patch, and LAN/WLAN-enabled multi-site data aggregation.

The company operates a dual-channel commercial model. In China, it sells directly to hospitals and healthcare institutions through a professional field sales force, with products deployed across thousands of facilities. Internationally, BI distributes through 1,000+ channel partners across 60+ countries, with particular depth in Europe and Latin America. The company also supplies OEM Holter hardware and software to medical device companies in the USA, Japan, and Germany, providing a recurring B2B revenue stream. Marketing is conducted through major international trade shows (MEDICA, FIME, CMEF) and cardiology academic conferences (China Heart Congress).

BI is ISO 13485 certified and holds CFDA and CE approvals for its products. The company has remained privately held with no disclosed external funding, ownership structure, or management team information publicly available. Revenue figures are not disclosed, though scale signals (10,000+ institutional users, 1,000+ distribution partners, 31 years of continuous operation) suggest a mid-sized medical device business. The most recent product launch tracked in the data is the 2020 Holter ECG & ABP Combination System, with newer components (Holter Patch BIP-03A, BI9900/BI9100 series) reflecting ongoing hardware evolution toward smaller, connected, multi-channel form factors.

Name

Biomedical Instruments

Legal name

Biomedical Instruments Co., Ltd.

Website

https://en.bi-biomed.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

101–250 employees

Short description

Biomedical Instruments Co., Ltd. is a privately held Shenzhen-based medical device manufacturer founded in 1993 that produces cardiocerebrovascular diagnostic and monitoring systems — Holter ECG, ambulatory blood pressure monitors, PC ECG, and a cloud-based cardiology information system — selling directly to thousands of hospitals in China and via 1,000+ distribution partners across 60+ countries, with additional OEM supply to major US, Japanese, and German device companies.

Ownership category

akta.pro rank

Product category

Cardiac Diagnostic Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Medical Equipment and Supplies Manufacturing (3391)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)

akta.pro secondary industries

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI), ECG/EKG & Heart Rhythm Monitors (Consumer) (CRACAQAC)

Keywords

• Holter ECG monitors
• Ambulatory blood pressure
• Cardiology information systems
• Cardiac diagnostic devices
• Telemedicine monitoring

Headquarters

HQ city

Shenzhen

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Medical Device Sales: Sale of cardiocerebrovascular diagnostic and monitoring devices including Holter systems, ABPM, PC ECG, and related software to hospitals and healthcare institutions worldwide.
2. OEM Hardware and Software: Provides OEM Holter hardware and software for world-renowned medical device companies in USA, Japan and Germany, creating recurring B2B revenue streams.
3. Software and System Sales: Sale of Cardiology Information System (CIS) software for hospital information management, telemedicine, mobile health, and home health care applications.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Biomedical Instruments (BI) designs, manufactures, and sells cardiocerebrovascular diagnostic and monitoring medical devices, including Holter ECG systems, ambulatory blood pressure monitors (ABPM), PC-based ECG machines, and a cloud-based Cardiology Information System (CIS) for centralized data management and telemedicine. The company sells directly to hospitals and healthcare institutions in China and through international distribution partners across 60+ countries, while also supplying OEM Holter hardware and software to medical device companies in the USA, Japan, and Germany.

Product overview

Biomedical Instruments (BI) is a professional manufacturer of cardiocerebrovascular diagnostic and monitoring devices, recognized as one of the top Holter ECG manufacturers in China. The product portfolio centers around four core product lines: Holter System (comprising New Holter Recorder BI9900/BI9100, standard Holter Recorder, Holter Patch BIP-03A, and Holter Software), Ambulatory Blood Pressure Systems (including BP60B and TeleABP BI5000/BI5000B), PC ECG, and the cloud-based Cardiology Information System (CIS) platform. The CIS platform serves as a unified information hub that connects all the diagnostic devices for centralized data management, storage, and telemedicine applications. The company also offers a Holter ECG & ABP Combination System for integrated cardiocerebrovascular monitoring. Products are sold to thousands of hospitals in China and distributed to more than 60 countries worldwide.

Differentiator

Problem solved

Functional benefit

Products and services

• Holter System Complete Holter monitoring system for 24-hour to 30-day continuous ECG recording and analysis, including recorders, software, and accessories for cardiocerebrovascular diagnostic monitoring in hospitals and clinics.
• New Holter Recorder (BI9900/BI9100) Advanced Holter recorder supporting 3-channel and 12-channel recording with up to 30 days recording time, color display, pacemaker detection, and patient position/movement detection. Dimensions: 80 x 59 x 18mm, Weight: 63g.
• Holter Patch (BIP-03A)

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• World-Renowned Medical Device Companies (USA, Japan, Germany)coreOEM/ Whitelabel/ Licensing PartnerBI provides OEM Holter hardware and software components for world-renowned medical device companies in USA, Japan and Germany, demonstrating strong technology partnership capabilities in the global medical device industry.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Nihon Kohden: Japanese medical device company with strong ECG, Holter, and patient monitoring lines; overlaps directly with BI's Holter and PC ECG offerings in Asia and global OEM channels.
• GE HealthCare: Major diagnostic and patient monitoring player (legacy GE/Marquette ECG line) offering resting ECG, Holter, and cardiology information systems used by hospitals worldwide — directly comparable to BI's product mix.
• Koninklijke Philips: Global healthcare technology incumbent with a broad cardiac care portfolio including Holter monitors, ECG, and patient monitoring platforms; competes directly with BI in ambulatory ECG and cardiology information systems.

Direct peers

• Spacelabs Healthcare: Specialist in ambulatory cardiac monitoring including Holter recorders and analysis software; a direct competitor to BI in Holter systems sold to hospitals and clinics globally.
• Mortara Instrument (Baxter): Specialist in resting ECG, Holter, and cardiac stress testing now part of Baxter; closely comparable to BI in ambulatory ECG hardware and analysis software.
• Edan Instruments: Chinese medical device manufacturer with overlapping ECG, Holter, patient monitoring, and OB/GYN products; a direct domestic competitor to BI in China and emerging markets.
• Schiller AG: Swiss manufacturer of ECG, Holter, and cardiopulmonary diagnostic devices; competes with BI across PC ECG, Holter, and ABPM in European and international hospital markets.
• Fukuda Denshi: Japanese medical electronics manufacturer specializing in ECG, Holter monitors, and patient monitoring; competes with BI in Holter/ECG, especially across Asian markets.

Regional players

• BPL Medical Technologies: Indian medical device manufacturer offering ECG, Holter, and patient monitoring products; competes with BI for emerging-market share and for OEM-style partnerships.

Emerging players

• CardioNet / iRhythm Technologies: US-based connected cardiac monitoring company (Zio patch) focused on extended-wear ambulatory ECG; increasingly competes with BI's Holter Patch in the shift to wearable, longer-duration monitoring.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biomedical Instruments